Carma Fund

Exciva develops clinical-stage biopharmaceutical therapies focused on addressing neuropsychiatric symptoms associated with dementia.

TECregen is a biotechnology company that develops thymus-rejuvenating biologics to restore immune function and T-cell responses.

Elkedonia is a biotech company dedicated to transforming antidepressant therapy.

Akribion Genomics develops gene-editing tools and cancer therapies using CRISPR nuclease technology.

Aignostics is an AI-powered precision diagnostics focused on pathology to assist with drug development and clinical research.

Symphera provides an all-in-one surgical system that makes minimally-invasive procedures more efficient.

Health services, insurers, and researchers use Thryve's wearable API to access data from 300+ wearables, medical devices, and other sources.

Allogenetics provides a unique solution to the problem of organ rejection following transplantation.

Heidelberg Epignostix is a pioneering start-up led by a dedicated team of DNA methylation-based tumor categorization experts.

Acorai is a medical device manufacturer of non-invasive intracardiac pressure monitoring to improve heart failure management.